KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Total Current Liabilities (2016 - 2026)

Edwards Lifesciences has reported Total Current Liabilities over the past 17 years, most recently at $1.8 billion for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 20.5% year-over-year to $1.8 billion; the TTM value through Dec 2025 reached $1.8 billion, up 20.5%, while the annual FY2025 figure was $1.8 billion, 20.5% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $1.8 billion at Edwards Lifesciences, up from $1.6 billion in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $1.9 billion in Q3 2024 and troughed at $799.0 million in Q1 2021.
  • A 5-year average of $1.2 billion and a median of $1.1 billion in 2023 define the central range for Total Current Liabilities.
  • Biggest five-year swings in Total Current Liabilities: soared 56.92% in 2024 and later fell 18.32% in 2025.
  • Year by year, Total Current Liabilities stood at $1.0 billion in 2021, then decreased by 0.96% to $1.0 billion in 2022, then grew by 16.92% to $1.2 billion in 2023, then rose by 25.92% to $1.5 billion in 2024, then increased by 20.5% to $1.8 billion in 2025.
  • Business Quant data shows Total Current Liabilities for EW at $1.8 billion in Q4 2025, $1.6 billion in Q3 2025, and $1.4 billion in Q2 2025.